US penalises Zimmer Biomet for repeat foreign bribery violations

Indiana-based medical device manufacturer Zimmer Biomet agreed on 12 January to pay a US$17.4 million criminal penalty after breaching the terms of a 2012 Foreign Corrupt Practices Act deferred prosecution agreement.

Unlock unlimited access to all Global Investigations Review content